All In MedTech

Device Trial Radar · NCT01226173

Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol

Study of Bio-Rad Laboratories Platelia Dengue NS1 Ag Assay in Blood Donors.

Last checked: Nov 20, 2026Latest source record: Sep 24, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

182,353

Actual

Start

Mar 2010

Primary completion

Aug 2012

Study completion Aug 2012

Sponsor

Lead sponsor
Bio-Rad LaboratoriesNot on our public-company list
Sponsor type
Industry
Collaborators
American National Red Cross; Centers for Disease Control and Prevention
First posted
Oct 22, 2010

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to screen blood donors for the presence of NS1 antigen of the dengue virus at the American Red Cross in Puerto Rico region (and Monroe County, Florida) using the Platelia Dengue NS1 Ag enzyme immunoassay.

Conditions

  • Mass Screening

Interventions

  • Bio-Rad Platelia Dengue NS1 Ag testDevice

    The purpose of the study is to screen blood donors for the presence of dengue NS1 antigen at the ARC in Puerto Rico region using the Bio-Rad Platelia Dengue NS1 Ag test.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of blood donors with repeatedly reactive Platelia Dengue NS1 Ag test results.Time frame: Two and a half years

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Community Blood Centers of Florida, Inc.

    Lauderhill, Florida

  • American Red Cross

    San Juan, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.